Yongwei Hu

686 total citations
32 papers, 435 citations indexed

About

Yongwei Hu is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yongwei Hu has authored 32 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Yongwei Hu's work include Cancer Risks and Factors (3 papers), Cancer-related molecular mechanisms research (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Yongwei Hu is often cited by papers focused on Cancer Risks and Factors (3 papers), Cancer-related molecular mechanisms research (3 papers) and Nanoplatforms for cancer theranostics (3 papers). Yongwei Hu collaborates with scholars based in China, United States and Finland. Yongwei Hu's co-authors include Hou-zhong Ding, Fang Cao, Kuo Wang, Wenzheng Fang, Yun Luo, Ying Chen, Guanzhen Yu, Cheng Guo, Zhongye Xu and Ya‐Ping Huang and has published in prestigious journals such as Nature Communications, Biomaterials and Scientific Reports.

In The Last Decade

Yongwei Hu

29 papers receiving 427 citations

Peers

Yongwei Hu

ONCOL

PRM

PFM

Guang‐Bin Sun China

Sally Järvelä Finland

Rui Zhong China

Kyungmi Yang South Korea

Xuefeng Liu China

Jiazhang Wei China

Chunhui Cui China

Chunyang Zhang China

Zaid Al-Wahab United States

Yingying Miao China

Guang‐Bin Sun China

Yongwei Hu

371 ×2.0

212 ×1.5

99 ×0.9

ONCOL

46 ×0.7

PRM

28 ×0.6

PFM

Citations per year, relative to Yongwei Hu Yongwei Hu (= 1×) peers Guang‐Bin Sun

Countries citing papers authored by Yongwei Hu

Since Specialization

Citations

This map shows the geographic impact of Yongwei Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongwei Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongwei Hu more than expected).

Fields of papers citing papers by Yongwei Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongwei Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongwei Hu. The network helps show where Yongwei Hu may publish in the future.

Co-authorship network of co-authors of Yongwei Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yongwei Hu. A scholar is included among the top collaborators of Yongwei Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongwei Hu. Yongwei Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Yongwei, Wang Li, Lei Lyu, et al.. (2025). Multi-faceted nanodrug reinforcing metalloimmunotherapy for hepatocellular carcinoma. Biomaterials. 329. 123899–123899.

Li, Xiaojing, Kun Li, Yongwei Hu, et al.. (2025). Tissue-resident peripheral helper T cells foster hepatocellular carcinoma immune evasion by promoting regulatory B-cell expansion. Chinese Medical Journal. 138(17). 2148–2158. 1 indexed citations

Chen, Gang, et al.. (2025). Research landscape and trends of human umbilical cord mesenchymal stem cell-derived exosomes. Stem Cell Research & Therapy. 16(1). 259–259. 1 indexed citations

Zhu, Dunru, et al.. (2025). Drug-loaded indocyanine green J-aggregates activate metalloimmunotherapy for sustained photothermal therapy of hepatocellular carcinoma. Journal of Nanobiotechnology. 23(1). 317–317. 2 indexed citations

Tao, Xueting, Jing Qian, & Yongwei Hu. (2024). Nutritional intervention in end-stage renal disease: a clinical trial study. Frontiers in Nutrition. 11. 1322229–1322229.

Hu, Yongwei, et al.. (2024). Alcohol use disorder disrupts BDNF maturation via the PAI-1 pathway which could be reversible with abstinence. Scientific Reports. 14(1). 22150–22150. 1 indexed citations

Li, Siqi, Kun Li, Kang Wang, et al.. (2023). Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells. Nature Communications. 14(1). 7709–7709. 41 indexed citations

Liu, Rongqiang, Shi‐Nan Wu, Hao Yu, et al.. (2023). Prediction model for hepatocellular carcinoma recurrence after hepatectomy: Machine learning-based development and interpretation study. Heliyon. 9(11). e22458–e22458. 7 indexed citations

Hu, Yongwei, Yanteng Xu, Rachel L. Mintz, et al.. (2022). Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis. Biomaterials. 293. 121942–121942. 40 indexed citations

10.

Xiang, Daohui, Zhiqiang Zhang, Yanbin Chen, Yongwei Hu, & Xiaofei Lei. (2021). Study of Tribological Properties of Textured Boron-Doped Diamond Film under Water Lubrication. Surfaces and Interfaces. 23. 100983–100983. 20 indexed citations

11.

Cao, Fang, et al.. (2021). Circulating long noncoding RNAs as potential biomarkers for stomach cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology. 19(1). 89–89. 13 indexed citations

12.

Guo, Cheng, et al.. (2021). Autophagy-Related Long Non-coding RNA Is a Prognostic Indicator for Bladder Cancer. Frontiers in Oncology. 11. 647236–647236. 38 indexed citations

13.

Zhang, Wen, Qing Zhao, Yongwei Hu, et al.. (2020). <p>Thalamic Atrophy Plays a Crucial Role in the Effect of Asymptomatic Carotid Stenosis on Cognitive Impairment</p>. Clinical Interventions in Aging. Volume 15. 2083–2094. 5 indexed citations

14.

Zhang, Qun, et al.. (2018). Therapeutic effect of Tandospirone citrate in Alzheimer's disease with depression and anxiety disorder. Zhonghua laonian yixue zazhi. 37(1). 41–44. 1 indexed citations

15.

Huang, Ya‐Ping, et al.. (2015). Glycated albumin is an optimal biomarker for gestational diabetes mellitus. Experimental and Therapeutic Medicine. 10(6). 2145–2149. 18 indexed citations

16.

Wang, Kuo, Fang Cao, Wenzheng Fang, et al.. (2013). Activation of SNAT1/SLC38A1 in human breast cancer: correlation with p-Akt overexpression. BMC Cancer. 13(1). 343–343. 57 indexed citations

17.

Cao, Fang, Yongwei Hu, Ping Li, et al.. (2013). Lymphangiogenic and Angiogenic Microvessel Density in Chinese Patients with Gastric Carcinoma: Correlation with Clinicopathologic Parameters and Prognosis. Asian Pacific Journal of Cancer Prevention. 14(8). 4549–4552. 20 indexed citations

18.

Cao, Fang, Kuo Wang, Rong Zhu, et al.. (2013). Clinicopathological Significance of Reduced SPARCL1 Expression in Human Breast Cancer. Asian Pacific Journal of Cancer Prevention. 14(1). 195–200. 20 indexed citations

19.

Nelson, Zakia C, Roberta M. Ray, Chunyuan Wu, et al.. (2010). Fruit and Vegetable Intakes Are Associated with Lower Risk of Breast Fibroadenomas in Chinese Women. Journal of Nutrition. 140(7). 1294–1301. 9 indexed citations

20.

Dijkstra, S., Roberta M. Ray, Chunyuan Wu, et al.. (2010). Biomarkers of Dietary Exposure Are Associated with Lower Risk of Breast Fibroadenomas in Chinese Women ,. Journal of Nutrition. 140(7). 1302–1310. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact